|
Trade Name
Albumex® 4
Presentation
|
| bet | 33/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Trade Name
|
Albumex® 4
|
Presentation
|
Albumex® 4 50 mL (2 g albumin), 250 mL (10 g albumin) and 500 mL (20 g albumin) bottles.
Each bottle contains Human Albumin 40 g/L, sodium 140 mmol/L, chloride 128 mmol/L and octanoate 6.4 mmol/L. Albumex® 4 contains trace amounts of aluminium (≤200 microg/L).
|
Dosage/Interval
|
Hypovolaemia/shock
10 to 20 mL/kg over 10 to 60 minutes titrated to clinical response.
Plasma exchange [normal saline recommended]:
Where total blood volume = 80 mL/kg; desired PCV = 0.55
Infusion rate to match 1:1 with the rate of removal of blood.
|
Maximum daily dose
|
|
Route
|
Intravenous
|
Preparation/Dilution
|
Administer undiluted
If the product has been stored in the refrigerator it should be allowed to reach room temperature before administration.
Always record the name and batch number of the product in order to maintain a link between the patient and the batch of the product.
Dilution of Albumex® 20 to Albumin 4% in case of unavailability of albumin 4%
Albumex® 20 can be diluted to an iso-oncotic protein concentration (4 to 5% albumin) prior to administration. Dilute in the proportion of 1 mL of Albumex® 20 to 4 mL of crystalloid solution (sodium chloride 0.9% or glucose 5% or 10%). DO NOT dilute with water since the lower tonicity will lead to intravascular haemolysis.
|
Administration
|
Hypovolaemia/shock: Intravenously over 10 to 60 minutes titrated to clinical response.
Plasma exchange [normal saline recommended]: Infusion rate to match 1:1 with the rate of removal of blood.
Albumex® 4 is packaged in a glass bottle that must be vented during use. [1]
|
Monitoring
|
Continuous cardiorespiratory and temperature observations.
|
|
|
| |
